Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

A September 2024 article in the journal Biomedicines reviewing the findings of clinical trials for ivermectin and chloroquine ...

Innovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.

Professor Richard Scolyer tells ABC Radio Sydney that a clinical trial is the next step for his melanoma research, but will ...

Ensuring every newborn has access to life-saving screening and treatment is both a moral and economic imperative.' ...

The center is the only program of its kind in Ohio and one of only a few in the nation. As part of Ohio State’s ...

The owners of a Pembroke Pines research clinic admitted in federal court this week that they faked data for two asthma drug ...

IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

SEQ is the only DLBCL MRD assay available for clinical use and covered by Medicare SEATTLE, (GLOBE NEWSWIRE) --  Adaptive ...

High levels of ammonia kill liver cells by damaging the mitochondria that power the cells. But this can be prevented using an existing drug due to start clinical trials, finds a new study in mice.